Areas of Expertise
Baxter Healthcare develops, manufactures and markets products that save and sustain the lives of people with haemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter combines expertise in medical devices and biotechnology to create products that advance patient care worldwide.
Baxter provides a comprehensive range of anaesthesia products including inhalation anaesthetics.
BioSurgery products stop bleeding and prevent blood loss, reduce adhesion formulation, seal tissue, fixate hernia mesh and provide synthetic bone graft substitutes during surgery.
At Baxter we understand that meeting your patients’ individual parenteral nutritional requirements is imperative. Therefore Baxter is committed to offering a range of parenteral nutrition products and services.
Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid may be appropriate. The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations. Baxter's Critical Care portfolio also includes Ceprotin, Flexbumin and Brevibloc.
Our long-standing commitment to provide therapies for people with haemophilia has led to innovations including the first plasma/albumin-free method recombinant Factor VIII therapy, and monoclonal antibody purification and heat treatment processes.
In July 2009, Baxter Healthcare acquired Willow Healthcare Services. Willow provides homecare services to patients across the UK including the delivery of medication, compounded drug products, ancillary items, medical equipment and nursing support direct to patients' homes.
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection.
Infusion Systems/IV Tubing
Infusion Systems includes a range of electronic infusion pumps, elastomeric infusors, administration sets, needlefree connectors and accessories for the administration of intravenous solutions, medications and blood transfusions, including non-DEHP administration sets.
IV Solutions, Drug Delivery and Irrigation
Baxter is one of the world's leading manufacturers of commercially prepared IV solutions and ready-to-use premixed drugs in flexible IV containers. Baxter also has a range of irrigation solutions and sets to suit a wide range of applications.
Our commitment to building strong, lasting relationships with pharmacies in the NHS and the private sector is rooted in 80 years of global experience and over 25 years of excellence in UK aseptic manufacturing.
Renal therapies: treatments for patients with kidney failure.
Baxter has long been committed to developing dialysis systems and solutions to enhance therapy outcomes for a wide range of patients with a wide range of needs.
Acute Blood Purification
Continuous Renal Replacement Therapy (CRRT) is an effective option for patients with AKI (Acute Kidney Injury).
Hospital haemodialysis is an option for kidney disease patients who choose to get treatment at a dialysis unit in a clinical setting or a hospital, rather than performing dialysis at home.
At our research centre, in Orth an der Donau, Austria, our scientists are working to apply our technologies both to new vaccines and also to improve the performance of Baxter's already marketed vaccines.